State of Ohio Veterinary Medical Licensure #9330
USDA APHIS National Veterinary Accreditation
Diplomate of the American College of Veterinary Internal Medicine (Cardiology)
State of California Veterinary Medical Licensure #20664
2003, BS, The Ohio State University, Columbus, Ohio
2008, DVM, The Ohio State University, Columbus, Ohio
2009, The Ohio State University, College of Veterinary Medicine, Columbus, Ohio
2011, Washington State University, College of Veterinary Medicine, Pullman, Washington
2012, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina
2013, PhD, Washington State University, Pullman, Washington
Active Research Grants
Co-Investigator, ACVIM Resident Resaerch Funding: Evaluating the Safety and Efficacy of Clevidine in Dogs with Mitral Valve Degeneration, Gunther-Harrington (Principal Investigator), American College of Veterinary Internal Medicine
Co-Investigator, Developing induced pluripotent stem cell-derived cardiomyocytes for disease modeling of canine dilated cardiomyopathy , Kol (Principal Investigator), Morris Animal Foundation
Principal Investigator, Spontaneous Hypertrophic Cardiomyopathy in Rhesus Macaques, (Principal Investigator), Myokardia Inc Translational Research Grant-in-Aid Program (TRGP)
Principal Investigator, Double-blind, randomized, placebo-controlled study of a novel veterinary rapamycin product in cats with subclinical hypertrophic cardiomyopathy (HCM), (Principal Investigator), Trivium Vet
Co-Investigator, Evaluation of shear-induced platelet activation, neutrophil extracellular trap formation and thrombosis in cats using an in vitro microfluidic model of cardiogenic arterial thromboembolism, Ronald Li (Principal Investigator), Morris Animal Foundation
Principal Investigator, The Single Intravenous Dose Effect of EDGEWISE1 in Cats with Hypertrophic Cardiomyopathy, (Principal Investigator), Edgewise Therapeutics
Principal Investigator, Unraveling the genetics of feline hypertrophic cardiomyopathy: a novel multiomics approach, (Principal Investigator), Morris Animal Foundation
Co-Principal Investigator, Expansion of the Feline MLII breeding colony and longitudinal evaluation of MLII associated cardiovascular disease, Bradbury A (Principal Investigator), ML2 Society
Co-Principal Investigator, Effects of dual antithrombotic therapy using rivaroxaban and clopidogrel on platelet function and coagulation parameters in cats., Stern JA, Li RHL (Principal Investigator), Everycat (Winn Feline) Foundation
Principal Investigator, Rapamycin to prevent cardiac remodeling in severe canine subvalvular aortic stenosis, (Principal Investigator), Morris Animal Foundation
Honors and Awards
2001 Ohio Academic Scholarship
2002 Ohio Academic Scholarship
2003 Ohio Academic Scholarship
2004 Columbus Academy of Veterinary Medicine Scholarship
2005 OSUCVM Summer Research Stipend Award
2006 Sam Segall Small Animal Medicine Scholarship
2007 Sam Segall Small Animal Medicine Scholarship
2007 College of Veterinary Medicine (OCUCVM) Research Day Award Winner
2009 Morris Animal Foundation - Pfizer Animal Health Fellowship
2010 Dr. Lynn A George Endowed Memorial Scholarship for Research
2011 Jessie Scholarship for Veterinary Cardiology and Neurology
Most Recent Five Book Chapters
2019 Oldach MS, Stern JA: Arrhythmogenic Right Ventricular Cardiomyopathy, Etienne Cote, (ed), Cote's Clinical Veterinary Advisor: Dogs and Cats (4th Edition), Philadelphia. 76-94.
2018 Stern JA: Congenital heart disease, Drobatz K, Hopper K, Silverstein D, (ed), Textbook of Small Animal Emergency Medicine, Hoboken. 325-329.
2018 Li RHL, Stern JA: Pulmonary thromboembolism, Drobatz K, Rozanski E, Silverstein D, Hopper K, (ed), Textbook of Small Animal Emergency Medicine, Hoboken. 266-273.
2017 Meurs KM, Stern JA: Chapter 4: Clinical genomics, Ettinger SJ, Feldman EC, Cote E, (ed), Textbook of Veterinary Internal Medicine, Eighth Edition, St. Louis, MO. 27-31.
2017 Meurs KM, Stern JA: Chapter 3: Basic genetics, Ettinger SJ, Feldman EC, Cote E, (ed), Textbook of Veterinary Internal Medicine, Eighth Edition, St. Louis, MO. 25-6.
Principal Investigator of the Stern Translational Cardiac Genetics and Pharmacogenomics Laboratory. Cardiac genetics and cardiac pharmacogenomics are the principal foci of my research. Specifically, mutation identification and subsequent evaluation of the role that these mutations play in the development of congenital heart disease as well as their effects on response to medical therapy. One of my research goals is to further propel the role of individualized medicine in veterinary cardiology patients. Additionally I am dedicated to the development of large animal models of human heart disease such as hypertrophic cardiomyopathy.
My specialty focus is veterinary cardiology. I am specifically interested in inherited heart disease and the application of genetic data to guide treatment and prognosis. Novel therapies for management of cardiac disease is a special focus of my clinical research.